4.7 Article

Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis

Journal

EUROPEAN JOURNAL OF CANCER
Volume 84, Issue -, Pages 228-238

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ejca.2017.07.034

Keywords

Mendelian randomisation; Colorectal cancer; Risk; Plasma fatty acids; Fatty acids

Categories

Funding

  1. Cancer Research UK [C1298/A8362]
  2. National Cancer Research Network
  3. Institute of Cancer Research
  4. Cancer Research UK
  5. Programme Grant funding from Cancer Research UK [C348/A12076]
  6. Oxford Comprehensive Biomedical Research Centre
  7. EU FP7 CHIBCHA grant
  8. Wellcome Trust Centre for Human Genetics, Oxford [090532/Z/09/Z]
  9. European Union (FP7) [258236]
  10. FP7 collaborative project SYSCOL [BM1206]
  11. COST Action in the UK [BM1206]
  12. Medical Research Council
  13. National Institute of Health Research Cancer Research Network
  14. Bobby Moore Fund from Cancer Research UK, Tenovus
  15. Kidani Trust
  16. Cancer Research Wales
  17. National Institute for Social Care and Health Research Cancer Genetics Biomedical Research Unit
  18. KFSHRC. In Finland
  19. Academy of Finland (Finnish Center of Excellence Program) [250345]
  20. Jane and Aatos Erkko Foundation
  21. Finnish Cancer Society
  22. European Research Council [ERC] [268648]
  23. Sigrid Juselius Foundation
  24. Nordic Information for Action eScience Center (NIASC)
  25. Nordic Center of Excellence - NordForsk [62721]
  26. State Research Funding of Kuopio University Hospital [B1401]
  27. Academy of Finland [271642, 263164, 100499, 205585, 265240, 263278]
  28. Ministry of Education and Culture, Finland
  29. Finnish Academy [139635]
  30. Wellcome Trust Sanger Institute
  31. ENGAGE - European Network for Genetic and Genomic Epidemiology, FP7-HEALTH-F4- [201413]
  32. National Institute of Alcohol Abuse and Alcoholism [AA-12502, AA-00145, K02AA018755]
  33. National Cancer Institute [UM1 CA167551]
  34. National Institutes of Health
  35. Australasian Colorectal Cancer Family Registry [U01 CA074778, U01/U24 CA097735]
  36. USC Consortium Colorectal Cancer Family Registry [U01/U24 CA074799]
  37. Mayo Clinic Cooperative Familial Registry for Colon Cancer Studies [U01/U24 CA074800]
  38. Ontario Familial Colorectal Cancer Registry [U01/U24 CA074783]
  39. Seattle Colorectal Cancer Family Registry [U01/U24 CA074794]
  40. University of Hawaii Colorectal Cancer Family Registry [U01/U24 CA074806]
  41. National Cancer Institute, National Institutes of Health [U01 CA122839, R01 CA143237]
  42. Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute [N01-CN-67009, N01-PC-35142, HHSN2612013000121]
  43. Hawai'i Department of Health [N01-PC-67001, N01-PC-35137, HHSN26120100037C]
  44. California Department of Public Health [HHSN261201000035C]
  45. SYSCOL
  46. Cancer Research UK [S_1474, 18927, 12076, 16459, 15116] Funding Source: researchfish
  47. Medical Research Council [MR/K018647/1, MC_PC_U127527198, MC_U127527198] Funding Source: researchfish
  48. MRC [MC_U127527198, MC_PC_U127527198, MR/K018647/1] Funding Source: UKRI
  49. European Research Council (ERC) [268648] Funding Source: European Research Council (ERC)
  50. Academy of Finland (AKA) [271642, 263164, 271642] Funding Source: Academy of Finland (AKA)

Ask authors/readers for more resources

Background: While dietary fat has been established as a risk factor for colorectal cancer (CRC), associations between fatty acids (FAs) and CRC have been inconsistent. Using Mendelian randomisation (MR), we sought to evaluate associations between polyunsaturated (PUFA), monounsaturated (MUFA) and saturated FAs (SFAs) and CRC risk. Methods: We analysed genotype data on 9254 CRC cases and 18,386 controls of European ancestry. Externally weighted polygenic risk scores were generated and used to evaluate associations with CRC per one standard deviation increase in genetically defined plasma FA levels. Results: Risk reduction was observed for oleic and palmitoleic MUFAs (OROA = 0.77, 95% CI: 0.65-0.92, P = 3.9 x 10(-3); ORPOA = 0.36, 95% CI: 0.15-0.84, P = 0.018). PUFAs linoleic and arachidonic acid had negative and positive associations with CRC respectively (ORLA = 0.95, 95% CI: 0.93-0.98, P = 3.7 x 10(-4); ORAA = 1.05, 95% CI: 1.02-1.07, P Z 1.7 x 10(-4)). The SFA stearic acid was associated with increased CRC risk (ORSA Z 1.17, 95% CI: 1.01-1.35, P = 0.041). Conclusion: Results from our analysis are broadly consistent with a pro-inflammatory FA profile having a detrimental effect in terms of CRC risk. (C) 2017 The Authors. Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available